Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis

References

• Aarts S, Seijkens TTP, Kusters PJH, et al. (2017). Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation. J Neuroinflamm 14:1. doi: 10.1186/s12974-017-0875-9.
   PubMed Web of Science ®Google Scholar
• Arnon R, Aharoni R. (2009). Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. J Neural Transm (Vienna) 116:1443–19. doi: 10.1007/s00702-009-0272-3.
   PubMed Web of Science ®Google Scholar
• Cai HY, Fu XX, Jiang H, et al. (2021). Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease. NPJ Parkinsons Dis 7:91. doi: 10.1038/s41531-021-00233-3.
   PubMed Web of Science ®Google Scholar
• Cai HY, Tian KW, Zhang YY, et al. (2018). Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model. Aging (Albany NY) 10:3507–27. doi: 10.18632/aging.101661.
   PubMedGoogle Scholar
• Chen H, Fu X, Jiang J, et al. (2019). C16 peptide promotes vascular growth and reduces inflammation in a neuromyelitis optica model. Front Pharmacol 10:1373. doi: 10.3389/fphar.2019.01373.
   PubMed Web of Science ®Google Scholar
• Cui YH, Le Y, Gong W, et al. (2002). Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol 168:434–42. doi: 10.4049/jimmunol.168.1.434.
   PubMed Web of Science ®Google Scholar
• Eng LF, Ghirnikar RS, Lee YL. (1996). Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21:511–25. doi: 10.1007/BF02527717.
   PubMed Web of Science ®Google Scholar
• Fang M, Sun Y, Hu Z, et al. (2013). C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model. Neuropharmacology 70:83–99. doi: 10.1016/j.neuropharm.2013.01.010.
   PubMed Web of Science ®Google Scholar
• Fu X, Chen H, Han S. (2020). C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation. Life Sci 256:117894. doi: 10.1016/j.lfs.2020.117894.
   PubMed Web of Science ®Google Scholar
• Fu XX, Cai HY, Jiang H, et al. (2021). Combined treatment with C16 peptide and angiopoietin-1 confers neuroprotection and reduces inflammation in 3-nitropropionic acid-induced dystonia mice. Aging (Albany NY) 13:19048–63. doi: 10.18632/aging.203354.
   PubMedGoogle Scholar
• Gaillard PJ, Appeldoorn CC, Rip J, et al. (2012). Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release 164:364–9. doi: 10.1016/j.jconrel.2012.06.022.
   PubMed Web of Science ®Google Scholar
• Han S, Arnold SA, Sithu SD, et al. (2010). Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is ­protective after spinal cord injury. Brain 133:1026–42. doi: 10.1093/brain/awq034.
   PubMed Web of Science ®Google Scholar
• Han S, Zhang F, Hu Z, et al. (2013). Dose-dependent anti-inflammatory and neuroprotective effects of an ανβ3 integrin-binding peptide. Mediators Inflamm 2013:268486. doi: 10.1155/2013/268486.
   PubMed Web of Science ®Google Scholar
• Herz J, Zipp F, Siffrin V. (2010). Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225:9–17. doi: 10.1016/j.expneurol.2009.11.019.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang J, Hu H, et al. (2020). Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer. Cell Cycle 19:3581–94. doi: 10.1080/15384101.2020.1852756.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang F, Yang J, et al. (2014). Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis. Exp Neurol 261:245–57. doi: 10.1016/j.expneurol.2014.05.013.
   PubMed Web of Science ®Google Scholar
• Karpus WJ. (2020). Cytokines and chemokines in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 204:316–26. doi: 10.4049/jimmunol.1900914.
   PubMed Web of Science ®Google Scholar
• López-Vales R, David S. (2019). Bioactive lipids in inflammation after central nervous system injury. Adv Exp Med Biol 1127:181–94. doi: 10.1007/978-3-030-11488-6_12.
   PubMed Web of Science ®Google Scholar
• Liang B, Wang X, Zhang N, et al. (2015). Angiotensin-(1-7) attenuates angiotensin II-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-κB pathways in HUVECs. Cell Physiol Biochem 35:2472–82. doi: 10.1159/000374047.
   PubMedGoogle Scholar
• Ma X, Jiang Y, Wu A, et al. (2010). Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One 5:e13489. doi: 10.1371/journal.pone.0013489.
   PubMed Web of Science ®Google Scholar
• Nakazato Y, Fujita Y, Nakazato M, et al. (2020). Neurons promote encephalitogenic CD4(+) lymphocyte infiltration in experimental autoimmune encephalomyelitis. Sci Rep 10:7354. doi: 10.1038/s41598-020-64363-z.
   PubMed Web of Science ®Google Scholar
• Pierson ER, Wagner CA, Goverman JM. (2018). The contribution of neutrophils to CNS autoimmunity. Clin Immunol 189:23–8. doi: 10.1016/j.clim.2016.06.017.
   PubMed Web of Science ®Google Scholar
• Qin Y, Li ZW, Yang Y, et al. (2014). Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites. J Drug Target 22:165–74. doi: 10.3109/1061186X.2013.851683.
   PubMed Web of Science ®Google Scholar
• Wang B, Tian KW, Zhang F, et al. (2016). Angiopoietin-1 and C16 peptide attenuate vascular and inflammatory responses in experimental allergic encephalomyelitis. CNS Neurol Disord Drug Targets 15:496–513. doi: 10.2174/1871527314666150821112546.
   PubMed Web of Science ®Google Scholar
• Wang H, Newton G, Wu  , et al. (2021). CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE. JCI Insight 6:e148719. doi: 10.1172/jci.insight.148719.
   PubMed Web of Science ®Google Scholar